Stem cell–like treatment injection after urethrotomy for urethral narrowing
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 2 trial tests whether injecting a patient’s own fat-derived cells during an endoscopic procedure can safely improve healing in bulbar urethral narrowing. It’s mainly for men with a specific type and short length of narrowing who can temporarily stop certain immune-suppressing medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man age 18 to 85 and sign informed consent
- Have bulbar urethral narrowing that is 3 cm or shorter
- Have needed at least one ureth dilation or urethrotomy in the last 24 months
- Be able to stop steroid (corticoid) or immune-suppressing medicines for about 1 month after the treatment, with doctor approval
- Have a BMI over 18 (so there’s enough body fat to collect for the treatment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether a local injection of fat-derived cells (made from your own tissue) can improve difficult Crohn’s disease fistulas around the anus. It’s designed for people whose Crohn’s fistulas have not responded to usual treatments.
This trial tests whether injecting stem cells or their byproducts can help men with erectile dysfunction who haven't responded well to standard treatments like Viagra. It aims to find a new option for improving sexual function.
This trial tests a new treatment made from stem cells for men with severe erectile dysfunction that hasn't improved with sildenafil (Viagra). It might help men who also have well-controlled type 2 diabetes.
This trial tests if stem cells can help restore erectile function in men who have had prostate cancer surgery (RALP). It is for men with localized, low-risk cancer and good sexual function before surgery.
This trial tests a drug-coated balloon to open a narrowed part of the urethra (the tube that carries urine out of the body) in men who have not had this problem before. The balloon releases a medicine to help keep the area open.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
Hear when a new Urethral Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.